RETINOID-ACTIVATING GENE THERAPY FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

$782,284FY2025Defense Health AgencyDOD

Dignity Health, San Francisco CA

Investigators

View source on USAspending →